Skip to content

Harm reduction funding meeting only 7% of global need

<i>The funding crisis for harm reduction</i> report.

Maraviroc fails to match tenofovir/emtricitabine for first-line HIV treatment

Maraviroc fails to match tenofovir/emtricitabine for first-line HIV treatment

Meta-analysis: only half the people who start PEP complete the course

Losses along the PEP cascade. Diagram taken from poster by Nathan Ford (TUPE153).

Globally, 1 in 12 MSM have been arrested for same-sex behaviour

Ifeanyi Orazulike, of the International Center for Advocacy on Rights to Health, speaking at AIDS 2014. Image by Roger Pebody (aidsmap.com).

Good adherence seen in study of intermittent PrEP

Jean-Michel Molina speaking at AIDS 2014. Photo: International AIDS Society/Steve Forrest.

Novel techniques probed in cure research

Photo: International AIDS Society/Steve Forrest

Romidepsin activates latent HIV, but does not decrease viral reservoir

Ole Schmeltz Søgaard, of Aarhus University Hospital in Denmark, presenting at AIDS 2014. Photo: International AIDS Society/Steve Forrest.

Adolescent deaths from AIDS rising, especially among boys

Image courtesy of UNICEF.

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment

Dr Deborah Persaud, principal researcher in the Mississippi baby case, speaking at AIDS 2014. Photo: International AIDS Society/Steve Forrest.